Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells

S Lazareno, NJ Buckley and FF Roberts

Department of Neuropharmacology, Glaxo Group Research Ltd., Ware Hertfordshire, United Kingdom.

We have carried out an extensive pharmacological characterization of muscarinic binding sites in rabbit lung and chicken heart in parallel with M1, M2, and M3 sites, [3H]Pirenzepine, a selective antagonist at M1 receptors, bound saturably and reversibly to membranes from chicken heart and rabbit lung. These binding sites were not M1 receptors, however, because the cardioselective antagonist himbacine had 10-fold higher affinity at these sites than at [3H]pirenzepine sites in rat and rabbit cortex (true M1 sites). We measured the inhibitory potency of 28 antagonists at [3H]N-methylscopolamine-labeled sites in chicken heart, rabbit lung, rat heart (M2 sites), and rat submandibular gland (M3 sites) and at M1 sites in rat cortex. The sites in rabbit lung were different from M1, M2, and M3 sites, because they had moderate to high affinity for M1-selective compounds (pirenzepine and telenzepine), M2- selective compounds (himbacine and methoctramine), and M3-selective compounds (hexahydrosiladifenidol and 4-diphenylacetoxy-N- methylpiperidine methiodide). The sites in chicken heart resembled most those in rabbit lung, with similar high affinity for secoverine, but they were not the same because tropicamide, diphenylacetoxybutynyl dimethylamine, and [3H]-N-methylscopolamine were more potent in rabbit lung. In a further series of experiments, we compared the affinity of six of the most discriminating antagonists in membranes from rabbit lung and NG108-15 cells, a neuroblastoma-glioma cell line reported to express the muscarinic m4 receptor gene. The antagonists had very similar affinities in the two tissues, the largest discrepancy being that pirenzepine was twice as potent in rabbit lung as in NG108-15 cells. Northern blots using probes designed to discriminate between five species of muscarinic receptor RNA detected only m4 mRNA in rabbit lung. We conclude that rabbit lung contains a muscarinic M4 binding site with a quite distinctive pharmacology and that chicken heart contains a receptor with similarities to the M4 sites. This is the first report to characterize native M4 binding sites in a nonneuronal mammalian tissue.

Volume 38, Issue 6, pp. 805-815, 12/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				D. Gautam, S.-J. Han, T. S. Heard, Y. Cui, G. Miller, L. Bloodworth, and J. Wess Cholinergic Stimulation of Amylase Secretion from Pancreatic Acinar Cells Studied with Muscarinic Acetylcholine Receptor Mutant Mice J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 995 - 1002. [Abstract] [Full Text] [PDF]

				N. Struckmann, S. Schwering, S. Wiegand, A. Gschnell, M. Yamada, W. Kummer, J. Wess, and R. V. Haberberger Role of Muscarinic Receptor Subtypes in the Constriction of Peripheral Airways: Studies on Receptor-Deficient Mice Mol. Pharmacol., December 1, 2003; 64(6): 1444 - 1451. [Abstract] [Full Text] [PDF]

				H. Wang, H. Han, L. Zhang, H. Shi, G. Schram, S. Nattel, and Z. Wang Expression of Multiple Subtypes of Muscarinic Receptors and Cellular Distribution in the Human Heart Mol. Pharmacol., April 16, 2001; 59(5): 1029 - 1036. [Abstract] [Full Text]

				X. M. Shao and J. L. Feldman Acetylcholine Modulates Respiratory Pattern: Effects Mediated by M3-Like Receptors in PreBotzinger Complex Inspiratory Neurons J Neurophysiol, March 1, 2000; 83(3): 1243 - 1252. [Abstract] [Full Text] [PDF]

				H. Shi, H. Wang, and Z. Wang Identification and Characterization of Multiple Subtypes of Muscarinic Acetylcholine Receptors and Their Physiological Functions in Canine Hearts Mol. Pharmacol., March 1, 1999; 55(3): 497 - 507. [Abstract] [Full Text]

				M. C. Olianas, A. Ingianni, C. Maullu, A. Adem, E. Karlsson, and P. Onali Selectivity Profile of Muscarinic Toxin 3 in Functional Assays of Cloned and Native Receptors J. Pharmacol. Exp. Ther., January 1, 1999; 288(1): 164 - 170. [Abstract] [Full Text]

				J. Liu and T. J. F. Lee Mechanism of prejunctional muscarinic receptor-mediated inhibition of neurogenic vasodilation in cerebral arteries Am J Physiol Heart Circ Physiol, January 1, 1999; 276(1): H194 - H204. [Abstract] [Full Text] [PDF]

				P. G. Szekeres and J. R. Traynor Delta Opioid Modulation of the Binding of Guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 Cell Membranes: Characterization of Agonist and Inverse Agonist Effects J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1276 - 1284. [Abstract] [Full Text]

				D. B. Hoover and D. A. Neely Differentiation of Muscarinic Receptors Mediating Negative Chronotropic and Vasoconstrictor Responses to Acetylcholine in Isolated Rat Hearts J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1337 - 1344. [Abstract] [Full Text]

				S. Matsumoto Functional Evidence of Excitatory M1 Receptors in the Rabbit Airway J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 531 - 539. [Abstract] [Full Text]

				I. C. Wood, A. Roopra, and N. J. Buckley Neural Specific Expression of the m4 Muscarinic Acetylcholine Receptor Gene Is Mediated by a RE1/NRSE-type Silencing Element J. Biol. Chem., June 14, 1996; 271(24): 14221 - 14225. [Abstract] [Full Text] [PDF]

				T. A. Bruning, P. C. Chang, M. G.C. Hendriks, P. Vermeij, M. Pfaffendorf, and P. A. van Zwieten In Vivo Characterization of Muscarinic Receptor Subtypes That Mediate Vasodilatation in Patients With Essential Hypertension Hypertension, July 1, 1995; 26(1): 70 - 77. [Abstract] [Full Text]